Cardiovascular Disease and Transgenerational Epigenetic Effects

Transgenerational Epigenetics

Volumn , Issue , 2014, Pages 321-341

  Zullo, Alberto ^a,b   Casamassimi, Amelia ^c   Mancini, Francesco Paolo ^a   Napoli, Claudio ^c,d  

^a UNIVERSITY OF SANNIO   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

Atherosclerosis; Cardiovascular disease; Cerebrovascular diseases; Environmental epigenetics; Epigenetics; Fetal epigenetic reprogramming; Lipid metabolism; Metabolic regulation; Metabolic syndrome; Transgenerational epigenetics

Indexed keywords

EID: 84903221662     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405944-3.00023-4     Document Type: Chapter

References (149)

1. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
2. O'Donnell M.J., Xavier D., Liu L., Zhang H., Chin S.L., Rao-Melacini P., Rangarajan S., Islam S., Pais P., McQueen M.J., Mondo C., Damasceno A., Lopez-Jaramillo P., Hankey G.J., Dans A.L., Yusoff K., Truelsen T., Diener H.C., Sacco R.L., Ryglewicz D., Czlonkowska A., Weimar C., Wang X., Yusuf S. INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
3. Mancini M., Ordovas Riccardi G., Rubba P., Strazzullo P. Nutritional and Metabolic Bases of Cardiovascular Disease 2011, Wiley-Balckwell.
4. Smith S.C. Current and future directions of cardiovascular risk prediction. Am J Cardiol 2006, 97:28A-32A.
5. Napoli C., Crudele V., Soricelli A., Al-Omran M., Vitale N., Infante T., Mancini F.P. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?. Circulation 2012, 125:2363-2373.
6. Drummond E.M., Gibney E.R. Epigenetic regulation in obesity. Curr Opin Clin Nutr Metab Care 2013, 16:392-397.
7. Napoli C., Infante T., Casamassimi A. Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage. Cardiovasc Res 2011, 92:367-374.
8. Daxinger L., Whitelaw E. Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet 2012, 13:153-162.
9. Guerrero-Bosagna C., Skinner M.K. Environmentally induced epigenetic transgenerational inheritance of phenotype and disease. Mol Cell Endocrinol 2012, 354:3-8.
10. Bell J.T., Tsai P.C., Yang T.P., Pidsley R., Nisbet J., Glass D., Mangino M., Zhai G., Zhang F., Valdes A., Shin S.Y., Dempster E.L., Murray R.M., Grundberg E., Hedman A.K., Nica A., Small K.S., Consortium MuTHER., Dermitzakis E.T., McCarthy M.I., Mill J., Spector T.D., Deloukas P. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 2012, 8:e1002629.
11. Zhang Y., Kent J.W., Lee A., Cerjak D., Ali O., Diasio R., Olivier M., Blangero J., Carless M.A., Kissebah A.H. Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a northern european family population. BMC Med Genomics 2013, 19:6-9.
12. Bollati V., Baccarelli A. Environmental epigenetics. Heredity 2010, 105:105-112.
13. Cortessis V.K., Duncan C.T., Levine A.J., Breton C.V., Mack T.M., Siegmund K.D., Haile R.W., Laird P.W. Environmental epigenetics: prospects for studying epigenetic mediation of exposure - response relationships. Hum Genet 2012, 131:1565-1589.
14. Zhang L., Hou D., Chen X., Li D., Zhu L., Zhang Y., Li J., Bian Z., Liang X., Cai X., Yin Y., Wang C., Zhang T., Zhu D., Zhang D., Xu J., Chen Q., Ba Y., Liu J., Wang Q., Chen J., Wang J., Wang M., Zhang Q., Zhang J., Zen K., Zhang C.Y. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012, 22:107-126.
15. Barker D.J. The origins of the developmental origins theory. J Intern Med 2007, 261:412-417.
16. Barker D.J. Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health 2012, 126:185-189.
17. Barker D.J. Fetal origins of cardiovascular disease. Ann Med 1999, 31:3-6.
18. Lorenzen J.M., Martino F., Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012, 107:245.
19. Grimaldi V., Mancini F.P., Casamassimi A., Al-Omran M., Zullo A., Infante T., Napoli C. Potential benefits of cell therapy in coronary heart disease. J Cardiol 2013, 62:267-276.
20. Paschalaki K.E., Starke R.D., Hu Y., Mercado N., Margariti A., Gorgoulis V.G., Randi A.M., Barnes P.J. Dysfunction of endothelial progenitor cells from smokers and COPD patients due to increased DNA damage and senescence. Stem Cells 2013, [Epub ahead of print.].
21. Gluckman P.D., Hanson M.A., Beedle A.S. Non-genomic transgenerational inheritance of disease risk. Bioessays 2007, 29:145-154.
22. Brock T.G. Epigenetics: The New Frontier for Vascular Diseases 2013, 23rd Annual Symposium of the International Cannabinoid Research Society, Vancouver, British Columbia, Canada, June 21-26.
23. Ho E., Bhindi R., Ashley E.A., Figtree G.A. Genetic analysis in cardiovascular disease: A clinical perspective. Cardiol Rev 2011, 19:81-89.
24. Dahme T., Katus H.A., Rottbauer W. Fishing for the genetic basis of cardiovascular disease. Dis Model Mech 2009, 2:18-22.
25. Visvikis-Siest S., Marteau J.B. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006, 17:139-151.
26. Scheuner M.T. Genetic predisposition to coronary artery disease. Curr Opin Cardiol 2001, 16:251-260.
27. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The Metabolic and Molecular Bases of Inherited Disease 2001, 2863-2913. McGraw-Hill Book Co, New York. 8th ed. C.S. Scriver (Ed.).
28. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997, 100:2680-2690.
29. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., Palinski W. Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999, 354:1234-1241.
30. van der Graaf A., Vissers M.N., Gaudet D., Brisson D., Sivapalaratnam S., Roseboom T.J., Jansen A.C., Kastelein J.J., Hutten B.A. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arterioscler Thromb Vasc Biol 2010, 30:2673-2677.
31. Narverud I., Iversen P.O., Aukrust P., Halvorsen B., Ueland T., Johansen S.G., Nenseter M.S., Sandset P.M., Ulven S.M., Ose L., Retterstøl K., Holven K.B. Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH. Thromb Res 2013, 131:178-182.
32. PDAY Research Group Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 1993, 13:1291-1298.
33. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E., Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998, 338:1650-1656.
34. Napoli C., Witztum J.L., de Nigris F., Palumbo G., D'Armiento F.P., Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999, 99:2003-2010.
35. Morrison K.M., Anand S.S., Yusuf S., Atkinson S.A., Schulze K.M., Rao-Melacini P., McQueen M.J., McDonald S., Persadie R., Hunter B., Bourgeois J., Jansen J.W., Teo K.K. FAMILY (Family Atherosclerosis Monitoring In earLY Life) Study investigators. Maternal and pregnancy related predictors of cardiometabolic traits in newborns. PLoS One 2013, 8:e55815.
36. Napoli C., Witztum J.L., Calara F., de Nigris F., Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000, 87:946-952.
37. Napoli C., de Nigris F., Welch J.S., Calara F.B., Stuart R.O., Glass C.K., Palinski W. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002, 105:1360-1367.
38. Bakker H., Jaddoe V.W.V. Cardiovascular and metabolic influences of fetal smoke exposure. Eur J Epidemiol 2011, 26:763-770.
39. Vidal A.C., Murphy S.K., Murtha A.P., Schildkraut J.M., Soubry A., Huang Z., Neelon S.E., Fuemmeler B., Iversen E., Wang F., Kurtzberg J., Jirtle R.L., Hoyo C. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes Lond 2013, 37:907-913.
40. Cohen G., Jeffery H., Lagercrantz H., Katz-Salamon M. Long-term reprogramming of cardiovascular function in infants of active smokers. Hypertension 2010, 55:722-728.
41. Power C., Atherton K., Thomas C. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis 2010, 211:643-648.
42. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
43. Dong M., Zheng Q., Ford S.P., Nathanielsz P.W., Rena J. Maternal obesity, lipotoxicity and cardiovascular diseases in offspring. J Mol Cell Cardiol 2013, 55:111-116.
44. Ng S.K., Olog A., Spinks A.B., Cameron C.M., Searle J., McClure R.J. Risk factors and obstetric complications of large for gestational age births with adjustments for community effects: results from a new cohort study. BMC Public Health 2010, 10:460.
45. Calkins K., Devaskar S.U. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 2011, 41:158-176.
46. Kyle U.G., Pichard C. The Dutch Famine of 1944-1945: a pathophysiological model of long-term consequences of wasting disease. Curr Opin Clin Nutr Metab Care 2006, 9:388-394.
47. Neel J.V. Diabetes mellitus: a thrifty genotype rendered detrimental by progress?. Am J Human Genet 1962, 14:353-362.
48. Hales C.N., Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
49. Tomat A.L., Costa Mde L., Arranz C.T. Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. Nutrition 2011, 27:392-398.
50. Napoli C., Lerman L.O., Sica V., Lerman A., Tajana G., de Nigris F. Microarray analysis: a novel research tool for cardiovascular scientists and physicians. Heart 2003, 89(6):597-604.
51. Heijmans B.T., Tobi E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., Slagboom P.E., Lumey L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008, 105:17046-17049.
52. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
53. Gillman M.W., Barker D., Bier D., Cagampang F., Challis J., Fall C., Godfrey K., Gluckman P., Hanson M., Kuh D., Nathanielsz P., Nestel P., Thornburg K.L. Meeting report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD). Pediatr Res 2007, 61:625-629.
54. Handy D.E., Castro R., Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 2011, 123:2145-2156.
55. Grossniklaus U., Kelly B., Ferguson-Smith A.C., Pembrey M., Lindquist S. Transgenerational epigenetic inheritance: how important is it?. Nat Rev Genet 2013, 14:228-235.
56. Chen K.C., Liao Y.C., Hsieh I.C., Wang Y.S., Hu C.Y., Juo S.H. OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: Novel mechanisms for cardiovascular diseases. J Mol Cell Cardiol 2012, 52:587-595.
57. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., Juo S.H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 2011, 25:1718-1728.
58. Liu M.E., Liao Y.C., Lin R.T., Wang Y.S., Hsi E., Lin H.F., Chen K.C., Juo S.H. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. Atherosclerosis 2013, 228:161-167.
59. Williams L., Seki Y., Vuguin P.M., Charron M.J. Animal models of in utero exposure to a high fat diet: A review. Biochim Biophys Acta 2013, [Epub ahead of print.].
60. Li C.C., Young P.E., Maloney C.A., Eaton S.A., Cowley M.J., Buckland M.E., Preiss T., Henstridge D.C., Cooney G.J., Febbraio M.A., Martin D.I., Cropley J.E., Suter C.M. Maternal obesity and diabetes induces latent metabolic defects and widespread epigenetic changes in isogenic mice. Epigenetics 2013, 8:602-611.
61. Yang Q.Y., Liang J.F., Rogers C.J., Zhao J.X., Zhu M.J., Du M. Maternal obesity induces epigenetic modifications to facilitate Zfp423 expression and enhance adipogenic differentiation in fetal mice. Diabetes 2013, 62:3727-3735.
62. Khalyfa A., Carreras A., Hakim F., Cunningham J.M., Wang Y., Gozal D. Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes Lond 2013, [Epub ahead of print.].
63. Alkemade F.E., Gittenberger-de Groot A.C., Schiel A.E., VanMunsteren J.C., Hogers B., van Vliet L.S., Poelmann R.E., Havekes L.M., Willems van Dijk K. DeRuiter MC: Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arterioscler Thromb Vasc Biol 2007, 27:2228-2235.
64. Alkemade F.E., van Vliet P., Henneman P., van Dijk K.W., Hierck B.P., van Munsteren J.C., Scheerman J.A., Goeman J.J., Havekes L.M. Gittenberger-de Groot AC, van den Elsen PJ, DeRuiter MC. Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature. Am J Pathol 2010, 176:542-548.
65. Nicholas L.M., Rattanatray L., Maclaughlin S.M., Ozanne S.E., Kleemann D.O., Walker S.K., Morrison J.L., Zhang S,Muhlhäusler B.S., Martin-Gronert M.S., McMillen I.C. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. FASEB J 2013, 27:3786-3796.
66. Nardelli C., Iaffaldano L., Ferrigno M., Labruna G., Maria Maruotti G., Quaglia F., Capobianco V., Di Noto R., Del Vecchio L., Martinelli P., Pastore L., Sacchetti L. Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women. Int J Obes Lond 2013, [Epub ahead of print].
67. Bouchard L., Thibault S., Guay S.P., Santure M., Monpetit A., St-Pierre J., Perron P., Brisson D. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 2010, 33:2436-2441.
68. Bouchard L., Hivert M.F., Guay S.P., St-Pierre J., Perron P., Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes 2012, 61:1272-1280.
69. Houde A.A., Hivert M.F., Bouchard L. Fetal epigenetic programming of adipokines. Adipocyte 2013, 2:41-46.
70. El Hajj N., Pliushch G., Schneider E., Dittrich M., Müller T., Korenkov M., Aretz M., Zechner U., Lehnen H., Haaf T. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 2013, 62:1320-1328.
71. Ruchat S.M., Houde A.A., Voisin G., St-Pierre J., Perron P., Baillargeon J.P., Gaudet D., Hivert M.F., Brisson D., Bouchard L. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 2013, 8. [Epub ahead of print.].
72. Bogdarina I., Welham S., King P.J., Burns S.P., Clark A.J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 2007, 100:520-526.
73. Tobi E.W., Lumey L.H., Talens R.P., Kremer D., Putter H., Stein A.D., Slagboom P.E., Heijmans B.T. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 2009, 18:4046-4053.
74. Baccarelli A., Rienstra M., Benjamin E.J. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010, 3:567-573.
75. Godfrey K.M., Barker D.J.P. Fetal nutrition and adult disease. Am J Clin Nutr 2000, 71:1344S-1352S.
76. Obermann-Borst S.A., Eilers P.H., Tobi E.W., de Jong F.H., Slagboom P.E., Heijmans B.T., Steegers-Theunissen R.P. Duration of breastfeeding and gender are associated with methylation of the LEPTIN gene in very young children. Pediatr Res 2013, 74:344-349.
77. Dolinoy D.C. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev 2008, 66:S7-11.
78. Dolinoy D.C., Weinhouse C., Jones T.R., Rozek L.S., Jirtle R.L. Variable histone modifications at the Avy metastable epiallele. Epigenetics 2010, 5:637-644.
79. Dolinoy D.C., Wiedman J.R., Waterland R.A., Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006, 114:567-572.
80. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A induced DNA hypomethylation in early development. Proc Natl Acad Sci 2007, 104:13056-13061.
81. Khalil N., Ebert J.R., Wang L., Belcher S., Lee M., Czerwinski S.A., Kannan K. Bisphenol A and cardiometabolic risk factors in obese children. Sci Total Environ 2014, 470-471:726-732.
82. Breton C.V., Byun H.M., Wenten M., Pan F., Yang A., Gilliland F.D. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009, 180:462-467.
83. Champagne F.A. Early environments, glucocorticoid receptors, and behavioral epigenetics. Behav Neurosci 2013, 127:628-636.
84. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease 1980, Harvard University Press, Cambridge, MA, 1-381.
85. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
86. Endo A., Kuroda M., Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum.J. Antibiot Japan 1976, 29:1346-1348.
87. Brown M.S., Goldstein J.L. Receptor-mediated control of cholesterol metabolism. Science 1976, 191:150-154.
88. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
89. Scandinavian Simvastatin Survival Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389.
90. Steinberg D., Witztum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?. Circulation 2002, 105:2107-2111.
91. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
92. Havel R. McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis-new perspectives. Am J Clin Nutr 1994, 59:795-796.
93. Hiltunen M.O., Turunen M.P., Häkkinen T.P., Rutanen J., Hedman M., Mäkinen K., Turunen A.M., Aalto-Setälä K., Ylä-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002, 7:5-11.
94. Lund G., Andersson L., Lauria M., Lindholm M., Fraga M.F., Villar-Garea A., Ballestar E., Esteller M., Zaina S. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004, 279:29147-29154.
95. Laukkanen M.O., Mannermaa S., Hiltunen M.O., Aittomaki S., Airenne K., Janne J., Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999, 19:2171.
96. Miranda T.B., Jones P.A. DNA methylation: the nuts and bolts of repression. J Cell Physiol 2007, 213:384.
97. Connelly J.J., Cherepanova O.A., Doss J.F., Karaoli T., Lillard T.S., Markunas C.A., Nelson S., Wang T., Ellis P.D., Langford C.F., Haynes C., Seo D.M., Goldschmidt-Clermont P.J., Shah S.H., Kraus W.E., Hauser E.R., Gregory S.G. Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. Hum Mol Genet 2013, [Epub ahead of print].
98. Kim M., Long T.I., Arakawa K., Wang R., Yu M.C., Laird P.W. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010, 5:e9692.
99. Zawadzki C., Chatelain N., Delestre M., Susen S., Quesnel B., Juthier F., Jeanpierre E., Azzaoui R., Corseaux D., Breyne J., Torpier G., Staels B., Van Belle E., Jude B. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 2009, 204:e4-e14.
100. Baccarelli A., Wright R., Bollati V., Litonjua A., Zanobetti A., Tarantini L., Sparrow D., Vokonas P., Schwartz J. Ischemic Heart Disease and Stroke in Relation to Blood DNA Methylation. Epidemiology 2010, 21:819-828.
101. Talens R.P., Jukema J.W., Trompet S., Kremer D., Westendorp R.G.J., Lumey L.H., Sattar N., Putter H., Slagboom P.E., Heijmans B.T. Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. Int J Epidemiol 2012, 41:106-115.
102. Kodach L.L., Jacobs R.J., Voorneveld P.W., Wildenberg M.E., Verspaget H.W., van Wezel T., Morreau H., Hommes D.W., Peppelenbosch M.P., van den Brink G.R., Hardwick J.C. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut 2011, 60:1544-1553.
103. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., Heldman A.W., Sussman M.S., Ouyang P., Milliken E.E., Issa J.P. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999, 43:985-991.
104. Wierda R.J., Geutskens S.B., Jukema J.W., Quax P.H., van den Elsen P.J. Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 2010, 14:1225-1240.
105. Cunnington M.S., Keavney B. Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus. Curr Atheroscler Rep 2011, 13:193-201.
106. Choi J.H., Nam K.H., Kim J., Baek M.W., Park J.E., Park H.Y., Kwon H.J., Kwon O.S., Kim D.Y., Oh G.T. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005, 25:2404-2409.
107. Small E.M., Frost R.J., Olson E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121:1022-1032.
108. Rayner K.J., Suárez Y., Dávalos A., Parathath S., Fitzgerald M.L., Tamehiro N., Fisher E.A., Moore K.J., Fernández-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
109. Rayner K.J., Sheedy F.J., Esau C.C., Hussain F.N., Temel R.E., Parathath S., van Gils J.M., Rayner A.J., Chang A.N., Suarez Y., Fernandez-Hernando C., Fisher E.A., Moore K.J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011, 121:2921-2931.
110. Soni K.B., Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992, 36:273-275.
111. Guay S.P., Brisson D., Lamarche B., Marceau P., Vohl M.C., Gaudet D., Bouchard L. DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability. Atherosclerosis 2013, 228:413-420.
112. Guay S.P., Brisson D., Munger J., Lamarche B., Gaudet D., Bouchard L. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 2012, 7:464-472.
113. Kumar A., Kumar S., Vikram A., Hoffman T.A., Naqvi A., Lewarchik C.M., Kim Y.R., Irani K. Histone and DNA methylation-mediated epigenetic downregulation of endothelial kruppel-like factor 2 by low-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol 2013, 33:1936-1942.
114. Dje N'Guessan P., Riediger F., Vardarova K., Scharf S., Eitel J., Opitz B., Slevogt H., Weichert W., Hocke A.C., Schmeck B., Suttorp N., Hippenstiel S. Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Arterioscler Thromb Vasc Biol 2009, 29:380-386.
115. Cash H.L., McGarvey S.T., Houseman E.A., Marsit C.J., Hawley N.L., Lambert-Messerlian G.M., Viali S., Tuitele J., Kelsey K.T. Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics 2011, 6:1257-1264.
116. Pearce M.S., McConnell J.C., Potter C., Barrett L.M., Parker L., Mathers J.C., Relton C.L. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int J Epidemiol 2012, 41:210-217.
117. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
118. Jiang Y., Zhang H., Sun T., Wang J., Sun W., Gong H., Yang B., Shi Y., Wei J. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. Acta Biochim Biophys Sin Shanghai 2012, 44:866-875.
119. van Straten E.M., Bloks V.W., Huijkman N.C., Baller J.F., van Meer H., Lütjohann D., Kuipers F., Plösch T. The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am J Physiol Regul Integr Comp Physiol 2010, 298:R275-R282.
120. Rangel-Salazar R., Wickström-Lindholm M., Aguilar-Salinas C.A., Alvarado-Caudillo Y., Døssing K.B., Esteller M., Labourier E., Lund G., Nielsen F.C., Rodríguez-Ríos D., Solís-Martínez M.O., Wrobel K., Wrobel K., Zaina S. Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages. BMC Genomics 2011, 12:582.
121. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 2006, 4:263-273.
122. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002, 16:22-26.
123. Okamura M., Inagaki T., Tanaka T., Sakai J. Role of histone methylation and demethylation in adipogenesis and obesity. Organogenesis 2010, 6:24-32.
124. Ahmadian M., Suh J.M., Hah N., Liddle C., Atkins A.R., Downes M., Evans R.M. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med 2013, 19:557-566.
125. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
126. Wang N., Yin R., Liu Y., Mao G., Xi F. Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update. Circ J 2011, 75:528-535.
127. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
128. Wakabayashi K., Okamura M., Tsutsumi S., Nishikawa N.S., Tanaka T., Sakakibara I., Kitakami J., Ihara S., Hashimoto Y., Hamakubo T., Kodama T., Aburatani H., Sakai J. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 2009, 29:3544-3555.
129. Koppen A., Kalkhoven E. Brown vs white adipocytes: the PPARgamma coregulator story. FEBS Lett 2010, 584:3250-3259.
130. Gelman L., Zhou G., Fajas L., Raspe E., Fruchart J.C., Auwerx J. p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively. J Biol Chem 1999, 274:7681-7688.
131. Takahashi N., Kavada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., Kawasaki H., Taira K., Yokoyama K.K., Kamei Y., Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferators-activated receptor-γ. J Biol Chem 2002, 77:16906-16912.
132. Sugii S., Evans R.M. Epigenetic codes of PPARγ in metabolic disease. FEBS Lett 2011, 585:2121-2128.
133. Collas P., Noer A., Timoskainen S. Programming the genome in embryonic and somatic stem cells. J Cell Mol Med 2007, 11:602-620.
134. Boonsanay V., Kim J., Braun T., Zhou Y. The emerging role of epigenetic modifiers linking cellular metabolism and gene activity in cardiac progenitor cells. TCM 2012, 22:77-81.
135. Chung S., Arrell D.K., Faustino R.S., Terzic A., Dzeja P.P. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol 2010, 48:725-734.
136. Yanes O., Clark J., Wong D.M., Patti G.J., Sánchez-Ruiz A., Benton H.P., Trauger S.A., Desponts C., Ding S., Siuzdak G. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 2010, 6:411-417.
137. Sinclair K.D., Allegrucci C., Singh R., Gardner D.S., Sebastian S., Bispham J., Thurston A., Huntley J.F., Rees W.D., Maloney C.A., Lea R.G., Craigon J., McEvoy T.G., Young L.E. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 2007, 104:19351-19356.
138. Dunn G., Bale T.L. Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology 2011, 152:2228-2236.
139. Kaati G., Bygren L.O., Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet 2002, 10:682-688.
140. Ng S.F., Lin R.C., Laybutt D.R., Barres R., Owens J.A., Morris M.J. Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring. Nature 2010, 467:963-966.
141. Rakyan V.K., Preis J., Morgan H.D., Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J 2001, 356:1-10.
142. Rakyan V.K., Chong S., Champ M.E., Cuthbert P.C., Morgan H.D., Luu K.V., Whitelaw E. Transgenerational inheritance of epigenetic states at the murine AxinFu allele occurs after maternal and paternal transmission. Proc Natl Acad Sci 2003, 100:2538-2543.
143. Blewitt M.E., Vickaryous N.K., Paldi A., Koseki H., Whitelaw E. Dynamic reprogramming of DNA methylation at an epigenetically sensitive allele in mice. PLoS Genet 2006, 2:e49.
144. Waterland R.A., Kellermayer R., Laritsky E., Rayco-Solon P., Harris R.A., Travisano M., Zhang W., Torskaya M.S., Zhang J., Shen L., Manary M.J., Prentice A.M. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet 2010, 6:e1001252.
145. King V., Dakin R.S., Liu L. Maternal Obesity Has Little Effect on the Immediate Offspring but Impacts on the Next Generation Endocrinology 2013, 154:2514-2524.
146. Buescher J.L., Musselman L.P., Wilson C.A., Lang T., Keleher M., Baranski T.J., Duncan J.G. Evidence for transgenerational metabolic programming in Drosophila. Dis Model Mech 2013, 6:1123-1132.
147. Fullston T., Ohlsson Teague E.M., Palmer N.O., Deblasio M.J., Mitchell M., Corbett M., Print C.G., Owens J.A., Lane M. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J 2013, 27:4226-4243.
148. Soubry A., Schildkraut J.M., Murtha A., Wang F., Huang Z., Bernal A., Kurtzberg J., Jirtle R.L., Murphy S.K., Hoyo C. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med 2013, 11:29.
149. Katoh M. Therapeutics targeting angiogenesis: Genetics and epigenetics, extracellular miRNAs and signaling networks. Int J Mol Med 2013, 32:763-767.